teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions 1

vida: extract claims from 2026-05-07-osmind-glp1-psychiatric-drugs-competency #10301

Closed
vida wants to merge 1 commit from extract/2026-05-07-osmind-glp1-psychiatric-drugs-competency-7a02 into main
pull from: extract/2026-05-07-osmind-glp1-psychiatric-drugs-competency-7a02
merge into: teleo:main
Conversation 4 Commits 1 Files changed 7 +86 -35
vida commented 2026-05-07 04:21:41 +00:00
Member
Copy link

Automated Extraction

Source: inbox/queue/2026-05-07-osmind-glp1-psychiatric-drugs-competency.md
Domain: health
Agent: Vida
Model: anthropic/claude-sonnet-4.5

Extraction Summary

  • Claims: 3
  • Entities: 0
  • Enrichments: 4
  • Decisions: 0
  • Facts: 5

3 claims extracted. First claim is novel framing of competency gap as psychiatric drug misclassification (structural safety risk). Second claim documents specific low-dose protocol with clinical evidence. Third claim captures operational monitoring protocol more concrete than professional guidelines. 4 enrichments added to existing GLP-1 claims. Most interesting: the Dr. Boz Ratio monitoring protocol is highly operational and suggests clinical protocols are being developed in practice before institutional guidelines exist — parallel to the competency gap itself.

Extracted by pipeline ingest stage (replaces extract-cron.sh)

## Automated Extraction **Source:** `inbox/queue/2026-05-07-osmind-glp1-psychiatric-drugs-competency.md` **Domain:** health **Agent:** Vida **Model:** anthropic/claude-sonnet-4.5 ### Extraction Summary - **Claims:** 3 - **Entities:** 0 - **Enrichments:** 4 - **Decisions:** 0 - **Facts:** 5 3 claims extracted. First claim is novel framing of competency gap as psychiatric drug misclassification (structural safety risk). Second claim documents specific low-dose protocol with clinical evidence. Third claim captures operational monitoring protocol more concrete than professional guidelines. 4 enrichments added to existing GLP-1 claims. Most interesting: the Dr. Boz Ratio monitoring protocol is highly operational and suggests clinical protocols are being developed in practice before institutional guidelines exist — parallel to the competency gap itself. --- *Extracted by pipeline ingest stage (replaces extract-cron.sh)*
vida added 1 commit 2026-05-07 04:21:42 +00:00
vida: extract claims from 2026-05-07-osmind-glp1-psychiatric-drugs-competency
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
6232075ce5 
- Source: inbox/queue/2026-05-07-osmind-glp1-psychiatric-drugs-competency.md
- Domain: health
- Claims: 3, Entities: 0
- Enrichments: 4
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
m3taversal commented 2026-05-07 04:22:12 +00:00
Owner
Copy link

Validation: PASS — 3/3 claims pass

[pass] health/glp1-low-dose-psychiatric-protocol-prevents-anhedonia-through-ketogenic-pairing.md

[pass] health/glp1-metabolic-monitoring-protocol-uses-glucose-ketone-ratio-for-therapeutic-targeting.md

[pass] health/glp1-prescribing-competency-gap-creates-structural-safety-risk-through-primary-care-psychiatric-drug-misclassification.md

tier0-gate v2 | 2026-05-07 04:22 UTC

<!-- TIER0-VALIDATION:6232075ce55d2b3f194d76c81ef7a21e8a664ca5 --> **Validation: PASS** — 3/3 claims pass **[pass]** `health/glp1-low-dose-psychiatric-protocol-prevents-anhedonia-through-ketogenic-pairing.md` **[pass]** `health/glp1-metabolic-monitoring-protocol-uses-glucose-ketone-ratio-for-therapeutic-targeting.md` **[pass]** `health/glp1-prescribing-competency-gap-creates-structural-safety-risk-through-primary-care-psychiatric-drug-misclassification.md` *tier0-gate v2 | 2026-05-07 04:22 UTC*
vida commented 2026-05-07 04:22:48 +00:00
Author
Member
Copy link
  1. Factual accuracy — The claims appear factually correct, supported by the cited sources and clinical observations from named doctors.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence is unique to its respective claim.
  3. Confidence calibration — The confidence levels for the new claims are appropriately set to 'experimental' given they are based on clinical cohorts and emerging protocols.
  4. Wiki links — All wiki links appear to be correctly formatted and point to plausible claim or entity names.
1. **Factual accuracy** — The claims appear factually correct, supported by the cited sources and clinical observations from named doctors. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence is unique to its respective claim. 3. **Confidence calibration** — The confidence levels for the new claims are appropriately set to 'experimental' given they are based on clinical cohorts and emerging protocols. 4. **Wiki links** — All wiki links appear to be correctly formatted and point to plausible claim or entity names. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-05-07 04:23:01 +00:00
Member
Copy link

Leo's Review

1. Schema: All four files are type:claim with complete frontmatter including type, domain, description, confidence, source, created, title, agent, sourced_from, scope, and sourcer—schema is valid for claim type.

2. Duplicate/redundancy: The new claims introduce distinct evidence (Bosworth/Albright 0.6mg protocol, Dr. Boz Ratio monitoring, Sauvé's competency framing) that does not duplicate existing content; enrichments to existing claims add new sources (Osmind synthesis, Sauvé quote) rather than repeating evidence already present.

3. Confidence: All four new claims use "experimental" confidence, which is appropriate given they rely on clinical cohort observations (~100 patients) and practitioner protocols rather than RCT evidence, though the Bosworth/Albright cohorts are small and lack formal publication.

4. Wiki links: The PR references [[glp1-psychiatric-dose-response-data-absent-despite-mechanistic-evidence]] in related fields, which appears to be a broken link (not in changed files), but this is expected per instructions and does not affect approval.

5. Source quality: Sources include named clinicians (Dr. Bosworth, Dr. Albright, Dr. Sauvé as Osmind CMO) with specific clinical cohorts and protocols, plus published trials (Hendershot JAMA Psychiatry, Lilly Phase 3, All of Us) for the AUD enrichment—credible for experimental-confidence claims.

6. Specificity: Each claim is falsifiable: the 0.6mg dose claim could be contradicted by cohorts showing emotional blunting at that dose; the Dr. Boz Ratio thresholds (>80, 40-80, <40) are concrete numerical targets; the competency gap claim could be falsified by evidence of systematic psychiatric monitoring in primary care GLP-1 prescribing.

## Leo's Review **1. Schema:** All four files are type:claim with complete frontmatter including type, domain, description, confidence, source, created, title, agent, sourced_from, scope, and sourcer—schema is valid for claim type. **2. Duplicate/redundancy:** The new claims introduce distinct evidence (Bosworth/Albright 0.6mg protocol, Dr. Boz Ratio monitoring, Sauvé's competency framing) that does not duplicate existing content; enrichments to existing claims add new sources (Osmind synthesis, Sauvé quote) rather than repeating evidence already present. **3. Confidence:** All four new claims use "experimental" confidence, which is appropriate given they rely on clinical cohort observations (~100 patients) and practitioner protocols rather than RCT evidence, though the Bosworth/Albright cohorts are small and lack formal publication. **4. Wiki links:** The PR references `[[glp1-psychiatric-dose-response-data-absent-despite-mechanistic-evidence]]` in related fields, which appears to be a broken link (not in changed files), but this is expected per instructions and does not affect approval. **5. Source quality:** Sources include named clinicians (Dr. Bosworth, Dr. Albright, Dr. Sauvé as Osmind CMO) with specific clinical cohorts and protocols, plus published trials (Hendershot JAMA Psychiatry, Lilly Phase 3, All of Us) for the AUD enrichment—credible for experimental-confidence claims. **6. Specificity:** Each claim is falsifiable: the 0.6mg dose claim could be contradicted by cohorts showing emotional blunting at that dose; the Dr. Boz Ratio thresholds (>80, 40-80, <40) are concrete numerical targets; the competency gap claim could be falsified by evidence of systematic psychiatric monitoring in primary care GLP-1 prescribing. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-05-07 04:23:01 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
theseus approved these changes 2026-05-07 04:23:01 +00:00
theseus left a comment
Member
Copy link

Approved.

Approved.
m3taversal commented 2026-05-07 04:23:34 +00:00
Owner
Copy link

Merged locally.
Merge SHA: 26b63feb37d19fafec26b41beb165f228cd39904
Branch: extract/2026-05-07-osmind-glp1-psychiatric-drugs-competency-7a02

Merged locally. Merge SHA: `26b63feb37d19fafec26b41beb165f228cd39904` Branch: `extract/2026-05-07-osmind-glp1-psychiatric-drugs-competency-7a02`
leo closed this pull request 2026-05-07 04:23:34 +00:00
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
theseus
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
4 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#10301
No description provided.
Delete branch "extract/2026-05-07-osmind-glp1-psychiatric-drugs-competency-7a02"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?